Virtus Investment Advisers’s Twist Bioscience TWST Stock Holding History

Virtus Investment Advisers’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,004	Closed	-$418K	–	681
2024 Q4	$418K	Hold	9,004	–	–	0.33%	106
2024 Q3	$407K	Hold	9,004	–	–	0.32%	101
2024 Q2	$444K	Hold	9,004	–	–	0.38%	86
2024 Q1	$309K	Hold	9,004	–	–	0.22%	127
2023 Q4	$332K	Sell	9,004 -2,740	-23%	-$63.4K	0.25%	124
2023 Q3	$238K	Hold	11,744	–	–	0.16%	154
2023 Q2	$240K	Buy	+11,744	New	+$176K	0.16%	168

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Virtus Investment Advisers's TWST Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Twist Bioscience (TWST) in Q1 2025, closing a stake of 9,004 shares — an estimated $418K sold.

Virtus Investment Advisers first reported a position in TWST in Q2 2023 and held it in 7 quarters. The position peaked at $444K in Q2 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

Virtus Investment Advisers reported no remaining Twist Bioscience position as of Q1 2025 after selling out during the quarter.
Virtus Investment Advisers sold 9,004 Twist Bioscience shares in Q1 2025, an estimated $418K.
Virtus Investment Advisers first reported a position in Twist Bioscience in Q2 2023 and held it in 7 quarters.
Virtus Investment Advisers's Twist Bioscience position peaked at $444K in Q2 2024.
262 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.